Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NELOPHER: Neoadjuvant Letrozole in Early-Stage Breast Cancer
NCT07394946Phase 2Not yet recruiting
- Sponsor
- Cancer Care Hospital & Research Centre Foundation
- Start
- Jun 2026
- Primary completion
- Jul 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in breast cancer, sponsored by Cancer Care Hospital & Research Centre Foundation. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07394946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07394946.